NVX vs. STEM, ELVA, GWH, CBAT, SES, CAN, MTLS, HEAR, TLS, and CTV
Should you be buying NOVONIX stock or one of its competitors? The main competitors of NOVONIX include Stem (STEM), Electrovaya (ELVA), ESS Tech (GWH), CBAK Energy Technology (CBAT), SES AI (SES), Canaan (CAN), Materialise (MTLS), Turtle Beach (HEAR), Telos (TLS), and Innovid (CTV). These companies are all part of the "computer and technology" sector.
Stem (NYSE:STEM) and NOVONIX (NASDAQ:NVX) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, community ranking, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.
Stem received 26 more outperform votes than NOVONIX when rated by MarketBeat users.
In the previous week, Stem had 1 more articles in the media than NOVONIX. MarketBeat recorded 2 mentions for Stem and 1 mentions for NOVONIX. Stem's average media sentiment score of 1.46 beat NOVONIX's score of 0.72 indicating that NOVONIX is being referred to more favorably in the news media.
61.6% of Stem shares are owned by institutional investors. Comparatively, 0.1% of NOVONIX shares are owned by institutional investors. 9.1% of Stem shares are owned by insiders. Comparatively, 23.7% of NOVONIX shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Stem has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, NOVONIX has a beta of 3.3, meaning that its share price is 230% more volatile than the S&P 500.
NOVONIX has a net margin of 0.00% compared to NOVONIX's net margin of -30.42%. Stem's return on equity of 0.00% beat NOVONIX's return on equity.
NOVONIX has lower revenue, but higher earnings than Stem.
Stem currently has a consensus price target of $6.39, indicating a potential upside of 192.42%. Given NOVONIX's higher probable upside, research analysts plainly believe Stem is more favorable than NOVONIX.
Summary
NOVONIX beats Stem on 8 of the 14 factors compared between the two stocks.
Get NOVONIX News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools